Time to initial review by oncology clinical pathways committees for new FDA approvals/label expansions von Caranfa, Christine L., Addonizio, Joanna, Desravines, Belinda, Rezaee, Daniel, Waid, Omar, Hamilton, Joanna M., Selesnick, Victoria H., Scalzo, Michael, Jackman, David Michael

Volltext

Novel use of clinical pathways to identify poor prognosis lung cancer patients: Implementation and outcomes von Jackman, David Michael, Rice, Matthew, Virkler, Nicholas, Desravines, Belinda, Selesnick, Victoria H., Scalzo, Michael, Siegel, Jocelyn H., Tulsky, James A., Jacobson, Joseph O.

Volltext